Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 16,146 shares at $642.62 ($10.5M) on 2021-09-13, disclosed to the SEC on 2021-09-15.
Open-market sale of $10.5M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $636.74 | 100 | $64K | 0.6% |
| 2 | $637.29 | 200 | $127K | 1.2% |
| 3 | $638.64 | 676 | $432K | 4.1% |
| 4 | $638.64 | 676 | $432K | 4.1% |
| 5 | $639.20 | 203 | $130K | 1.2% |
| 6 | $639.20 | 203 |
| $130K |
| 1.2% |
| 7 | $640.77 | 100 | $64K | 0.6% |
| 8 | $641.12 | 100 | $64K | 0.6% |
| 9 | $642.62 | 400 | $257K | 2.5% |
| 10 | $643.49 | 100 | $64K | 0.6% |
| 11 | $644.89 | 100 | $64K | 0.6% |
| 12 | $645.66 | 100 | $65K | 0.6% |
| 13 | $647.58 | 151 | $98K | 0.9% |
| 14 | $647.58 | 151 | $98K | 0.9% |
| 15 | $648.48 | 962 | $624K | 6.0% |
| 16 | $648.48 | 962 | $624K | 6.0% |
| 17 | $649.46 | 838 | $544K | 5.2% |
| 18 | $649.46 | 838 | $544K | 5.2% |
| 19 | $650.40 | 1,800 | $1.2M | 11.2% |
| 20 | $651.10 | 3,712 | $2.4M | 23.1% |
| 21 | $651.10 | 3,712 | $2.4M | 23.1% |
| 22 | $652.26 | 62 | $40K | 0.4% |
| Total | $648.42 avg | 16,146 | $10.5M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |